Related Experiment Video
Updated: Dec 23, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.1K
Peanut Allergy: New Advances and Ongoing Controversies
Elissa M Abrams1, Edmond S Chan2, Scott Sicherer3
1Section of Allergy and Clinical Immunology, Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada; elissa.abrams@gmail.com.
Pediatrics
|April 19, 2020
Summary
Early peanut introduction may prevent peanut allergy in children, a common food allergy. New diagnostics and immunotherapies offer hope for management and desensitization.
Area of Science:
- Pediatric Allergy and Immunology
- Food Allergy Pathogenesis
- Allergen Exposure and Sensitization
Background:
- Peanut allergy is a prevalent childhood food allergy with increasing incidence.
- The dual-allergen exposure hypothesis suggests skin sensitization to peanut contributes to allergy development.
- Emerging evidence supports early peanut introduction for allergy prevention.
Purpose of the Study:
- To review the current understanding of peanut allergy development, diagnosis, and management.
- To highlight the role of early allergen exposure in prevention strategies.
- To discuss emerging diagnostic tools and therapeutic interventions.
Main Methods:
- Literature review of recent studies on peanut allergy.
- Analysis of the dual-allergen exposure hypothesis.
- Evaluation of current and emerging diagnostic and therapeutic approaches.
Main Results:
- Transcutaneous sensitization is a likely mechanism for peanut allergy.
- Early peanut introduction shows promise for allergy prevention.
- Current diagnostics have limitations; component-resolved diagnostics may improve specificity.
- Oral and epicutaneous immunotherapy are promising for desensitization.
Conclusions:
- Early peanut introduction is a key strategy for primary prevention.
- Advanced diagnostics and immunotherapies are transforming peanut allergy management.
- Focus on quality of life and novel desensitization methods is crucial.
Related Concept Videos
Allergic Reactions
31.7K
Overview
31.7K
Cross-reactivity
32.7K
Overview
32.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Asthma: Pathogenesis and Management
1.1K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K

